Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2021-02-17 Director's Dealing
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
FORM 5 SUBMISSION
Director's Dealing
2021-02-17 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 14, 2021, reporting changes in the company's board of directors and senior management. It details the retirement of a director, appointment of a new director, changes in board size, and appointment of a lead independent director. The content focuses exclusively on board and management changes without financial statements or other report types. Therefore, it fits the category of Board/Management Information (MANG). The document length is 6438 characters, which is sufficient to contain substantive information rather than a brief announcement. No financial data or earnings information is present, so it is not an earnings release or annual report. Hence, the classification is MANG with high confidence.
2021-02-16 English
PRIMARY DOCUMENT
Director's Dealing
2021-02-16 English
10-K
Annual Report FY 2020
2021-02-11 English
SCHEDULE 13G/A
Major Shareholding Notification
2021-02-10 English
SEC SCHEDULE 13G
Major Shareholding Notification
2021-02-04 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.